Psychedelic trip sitting, dosages and intensities
Supplementing clinical studies with anecdotal reports
Bibliographic Data
| ID | 4652089 |
|---|---|
| Authors | Liam B Engel (0000-0001-8030-7210, Royal Botanic Garden Sydney, corresponding author), Sascha Thal (0000-0001-9028-9335, Murdoch University), Stephen J Bright (0000-0002-9001-032X, Edith Cowan University), Mitchell Low (0000-0002-7928-0089, Western Sydney University) |
| Year | 2024 |
| Publication date | 2024-07-17 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Psychedelic Studies (JOURNAL) |
| Journal identifiers | ISSN: 2559-9283 • E-ISSN: 2559-9283 |
| Publisher | Akademiai Kiado Zrt (PUBLISHER) |
| DOI | 10.1556/2054.2024.00377 |
| OpenAlex | W4400732567 |
| Language | EN |
| Citations received | 1 |
| References cited | 27 |
Background and aimsOnline communities provide insights into psychedelic consumption, assisting in identification of trends, informing both harm reduction provisions and clinical research. This study extracts forum data on psychedelic substances, dosages, and administration routes, categorising and analysing self-reported consumption to inform care services and guide clinical work with psychedelics.MethodsPosts (n = 660) from online psychedelic forums (The Shroomery and DMT Nexus) on 'trip sitting' were analysed. Using a Delphi-style expert panel review facilitated by LE, we created drug weight and intensity charts (threshold, light, common, strong and heavy dosages) for psychedelics discussed in these posts. The psychedelic substance, dosage intensity and route of administration [ROA] (smoked/vaporised, oral, injected, insufflated and undisclosed) frequencies and exploring correlations with perceived need for assistance from a psychedelic carer were mapped and correlated with perceived need for psychedelic care.ResultsPsychedelics appearing in our data were 5-MeO-DMT, ayahuasca, changa, LSA, LSD and psilocybin. There was greater commonality between clinical studies and 'common' doses determined through the Delphi method, for more extensively researched substances like LSD and psilocybin. Many posts indicated opinions that psychedelic care was unnecessary or optional for consumers, particularly for LSD and LSA. 5-MeO-DMT was strongly associated with a perceived need for care. A correlation was identified between greater psychedelic purity, dosage intensity, and a perceived need for care. Oral administration, the most common ROA, showed lower dosage intensity.ConclusionMore research is needed to understand factors influencing psychedelic care practices. Educational information, emphasizing risk management strategies, should be provided to psychedelic consumers, emphasising psychedelic products and administration methods more likely to be dosed at a strong or heavy intensity
Delphi method · Dose · Hallucinogen · Mescaline · Psilocybin · Biochemical Analysis and Sensing Techniques · Chemical synthesis and alkaloids · Medicine · Psychedelics and Drug Studies · Psychology · Pharmacology
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer
Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
The Delphi method as a research tool
Inclusion of people of color in psychedelic-assisted psychotherapy
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression
Hallucinogens
Psilocybin with psychological support for treatment-resistant depression
Psychedelics
Trial of Psilocybin versus Escitalopram for Depression
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Psilocybin-assisted treatment for alcohol dependence
The Use of LSD-25 in the Treatment of Alcoholism and Other Psychiatric Problems
A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression
Sober sitter or coconsumer? Psychedelics, online forums and preferences for interpersonal interactions
The Origins of Inebriation
Psychedelic Forum Member Preferences for Carer Experience and Consumption Behavior
Presence, Trust, and Empathy
Use of psilocybin ("mushrooms") among US adults
Long-lasting analgesic effect of the psychedelic drug changa
| Citations per year | 1 |
|---|---|
| Citation span | 2025 - 2025 (1) |
| Highly cited | No |